Iron, Folic Acid & Hematinics

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.

Methylcobalamin / Mecobalamin Tablets (500mcg, 1500mcg) and Orally Disintegrating Strips (1500mcg; alone or with Alpha Lipoic Acid, Benfotiamine, Folic Acid, Pyridoxine) is an active neurotropic coenzyme form of vitamin B12 on the WHO Model List framework. It functions as a methyl donor in homocysteine-to-methionine conversion, essential for phosphatidylcholine and myelin sheath synthesis, nucleic acid synthesis, and nerve regeneration. Indicated for diabetic peripheral neuropathy, alcoholic neuropathy, megaloblastic anemia, drug-induced neuropathy (isoniazid, metformin), and sciatica.

Methylcobalamin 1500mcg, Vitamin B6 (Pyridoxine) 5mg Benfotiamine 50mg, Alpha Lipoic Acid 200mg, Folic Acid 5mg and Biotin 5mg Capsules is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.

Ferric Carboxymaltose Injection (50mg/ml elemental iron, 500mg/10ml vial) is a non-dextran, macromolecular colloidal iron complex on the WHO Model List of Essential Medicines. Its polynuclear iron(III)-hydroxide core is stabilized by a carbohydrate carboxymaltose matrix that tightly binds iron, preventing free labile toxic iron release while delivering rapid targeted iron uptake to the reticuloendothelial system for ferritin storage and hemoglobin synthesis. Allows rapid administration of high single doses (up to 1000 mg elemental iron in 15 minutes). Indicated for treatment of iron deficiency anemia when oral iron preparations are ineffective or cannot be tolerated, and in non-dialysis chronic kidney disease, heart failure (NYHA class II-III with iron deficiency), and severe postpartum/menorrhagic anemia.

Methylcobalamin Injection (500mcg/ml, 1500mcg/ml) is a parenteral coenzyme form of vitamin B12 on the WHO Model List framework. Bypasses intestinal intrinsic factor absorption barriers to replenish intracellular cobalamin pools, promoting neuronal myelin sheath synthesis, axonal regeneration, and methionine synthase remethylation of homocysteine. Indicated for severe peripheral neuropathy, diabetic neuropathy, megaloblastic anemia, subacute combined degeneration of the spinal cord, and pernicious anemia.